Market Cap
$18.6B
LYB
LyondellBasell Industries N.V.
$58.78 ▲ +1.73%
Prev close $57.78Market cap$18.6B
ConsensusHold
12-mo target$67.94 (+15.6%)
▲ Neutral
Analyst conviction 5/10
Biotech & Drug Discovery
Snapshot
The big-picture read on LYB right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Hold (48%)
Insider Activity
$0.00 buy / $27.0M sell
Insider Net $
-$27.0M
Social Sentiment
50° Neutral
SEC Reports
6
Press Releases
6
Congressional
3 trades
Price chart 30d -11.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Jul 31, 2026 SEC Short Volume: LYB — 62.2% short (0.8M / 1.4M)
Short: 839,832 | Exempt: 261 | TRF Vol: 1,350,506 | Short Ratio: 62.2% | Off-exchange volume (dark p
LyondellBasell reported Q2 2026 EPS excluding identified items of $4.30, a 25.6% beat vs consensus of $3.42, driven by s
8-K — Impact 6/10
LyondellBasell announced a collaboration with Mondelez, Amcor, and Taghleef to produce flexible packaging for Marabou ch
Impact 2/10
LyondellBasell issued a press release announcing the date for its second-quarter 2026 earnings release (July 31, 2026) a
PRESS-RELEASE — Impact 2/10
Jun 30, 2026 Insider
KAMSKY VIRGINIA A was granted 561 shares
Director
Jun 30, 2026 Insider
Karlin Bridget E was granted 615 shares
Director
Jun 30, 2026 Insider
May 29, 2026 SEC KAMSKY VIRGINIA A surrendered for taxes 100 shares
Director @ $52.65 ($5.3K)
LyondellBasell amended its accounts receivable securitization facility, extending the maturity to June 25, 2027 and redu
8-K — Impact 3/10
Analyst ratings buy % +380.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
48% rate it Buy or better · 25 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 30, 2026 | Citigroup | DOWNGRADE | Neutral | 55% |
| Sep 25, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Sep 11, 2026 | Keybanc | INITIATE | Sector Weight | 52% |
| Aug 5, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Aug 4, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Aug 3, 2026 | BMO Capital | MAINTAIN | Market Perform | 53% |
| Aug 3, 2026 | Mizuho | MAINTAIN | Neutral | 52% |
| Aug 3, 2026 | JP Morgan | UPGRADE | Overweight | 55% |
| Jul 20, 2026 | Morgan Stanley | MAINTAIN | Overweight | 55% |
| Jul 6, 2026 | BMO Capital | MAINTAIN | Market Perform | 53% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 10 | 9 | 3 | 1 | 48% | |
| Aug 1, 2026 | 2 | 9 | 10 | 3 | 1 | 44% | |
| Jul 1, 2026 | 2 | 9 | 10 | 3 | 1 | 44% | |
| Jun 1, 2026 | 2 | 9 | 10 | 3 | 1 | 44% | |
| May 1, 2026 | 2 | 7 | 12 | 3 | 1 | 36% | |
| Apr 1, 2026 | 2 | 7 | 13 | 2 | 1 | 36% | |
| Mar 1, 2026 | 0 | 1 | 17 | 8 | 2 | 4% | |
| Feb 1, 2026 | 0 | 1 | 17 | 8 | 2 | 4% |
Price targets
Where 17 covering analysts think LYB trades over the next 12 months.
$67.94 +15.6% upside Buy
Current$58.78 Low$56.00 Median$66.00 High$88.00 17 analysts
$56.00$88.00
Analyst rating Hold· 2.8/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
6 SEC filing reports analyzed · 1 bullish, 0 bearish, 1 mixed, 4 neutral · avg impact 3.8/10.Plus 6 press releases.
BULLISH8-K6/10
LyondellBasell reported Q2 2026 EPS excluding identified items of $4.30, a 25.6% beat vs consensus o
Jul 31, 2026
NEUTRALPRESS-RELEASE2/10
LyondellBasell issued a press release announcing the date for its second-quarter 2026 earnings relea
Jul 6, 2026
NEUTRAL8-K3/10
LyondellBasell amended its accounts receivable securitization facility, extending the maturity to Ju
May 29, 2026
MIXEDPRESS-RELEASE6/10
LyondellBasell reported Q1 2026 GAAP EPS of $0.38 (vs consensus $0.28, beat) but GAAP net income of
May 1, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: LYB — 62.2% short (0.8M / 1.4M)
Short: 839,832 | Exempt: 261 | TRF Vol: 1,350,506 | Short Ratio: 62.2% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: LYB — 57.1% short (0.6M / 1.1M)
Short: 605,567 | Exempt: 1,188 | TRF Vol: 1,059,987 | Short Ratio: 57.1% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
short_volume
Short Volume: LYB — 63.8% short (0.9M / 1.4M)
Short: 894,096 | Exempt: 27 | TRF Vol: 1,401,303 | Short Ratio: 63.8% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: LYB — 67.9% short (0.7M / 1.0M)
Short: 669,348 | Exempt: 1,160 | TRF Vol: 985,586 | Short Ratio: 67.9% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: LYB — 59.5% short (0.6M / 0.9M)
Short: 553,593 | Exempt: 710 | TRF Vol: 930,957 | Short Ratio: 59.5% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $2.59 | $2.16–$2.96 | 156.2% | -6.2% | 7↑ 6↓ | $9.0B | 16 |
| Next Q | $1.70 | $1.26–$2.30 | 755.4% | -3.4% | 7↑ 6↓ | $8.3B | 16 |
| Current FY | $9.11 | $8.50–$10.05 | 435.9% | -2.1% | 12↑ 3↓ | $33.3B | 18 |
| Next FY | $6.22 | $4.58–$8.63 | -31.7% | -3.9% | 9↑ 5↓ | $32.1B | 16 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $2.588 | — |
| 7d ago | $2.659 | -0.071 |
| 30d ago | $2.759 | -0.171 |
| 60d ago | $2.831 | -0.243 |
| 90d ago | $3.280 | -0.692 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
21 insiders, 50 transactions. Net -$27.0M — $0.00 bought, $27.0M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | KAMSKY VIRGINIA A | Director | AWARD | 561 | — | — |
| Jun 30, 2026 | Karlin Bridget E | Director | AWARD | 615 | — | — |
| Jun 30, 2026 | KAMSKY VIRGINIA A | Director | TAX W/H | 100 | $52.65 | $5.3K |
| Jun 30, 2026 | Karlin Bridget E | Director | TAX W/H | 73 | $52.65 | $3.8K |
| May 22, 2026 | AIGRAIN JACQUES | Director | TAX W/H | 575 | $69.72 | $40.1K |
| May 22, 2026 | Benet Lincoln E | Director | TAX W/H | 1,410 | $69.72 | $98.3K |
| May 22, 2026 | Buchanan Robin W.T. | Director | TAX W/H | 1,247 | $69.72 | $86.9K |
| May 22, 2026 | Hanley Michael Sean | Director | TAX W/H | 540 | $69.72 | $37.6K |
| May 22, 2026 | Dudley Robert W. | Director | TAX W/H | 708 | $69.72 | $49.4K |
| May 22, 2026 | KAMSKY VIRGINIA A | Director | TAX W/H | 593 | $69.72 | $41.3K |
Congressional trades
LYB trades disclosed by members of Congress, with disclosure delay.
2 members · 2 buys / 1 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | LyondellBasell Industries NV | Feb 16, 2026(39d) |
| Sep 23, 2025 | Julie Johnson | D | HOUSE | SELL | $1,001 - $15,000 | LyondellBasell Industries NV | Aug 6, 2026(318d) |
| Sep 23, 2025 | Julie Johnson | D | HOUSE | BUY | $1,001 - $15,000 | LyondellBasell Industries NV | Aug 6, 2026(318d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for LYB.
Shares short
13,350,742
Settlement Sep 15, 2026
Change vs prior
-4.3%
Semi-monthly cycle
Days to cover
4.0
At avg daily volume
Of shares outstanding
≈4.1%
Estimate — not % of float
All LYB filing & press-release reports (12)
- 8-K reportJul 31, 2026
- PRESS-RELEASE reportJul 7, 2026
- PRESS-RELEASE reportJul 6, 2026
- 8-K reportMay 29, 2026
- PRESS-RELEASE reportMay 22, 2026
- PRESS-RELEASE reportMay 1, 2026
- PRESS-RELEASE reportMay 1, 2026
- PRESS-RELEASE reportApr 10, 2026
- DEFA14A reportApr 10, 2026
- PRESS-RELEASE reportApr 6, 2026
- PRESS-RELEASE reportMar 16, 2026
- PRESS-RELEASE reportFeb 26, 2026